Dr. Sammy Elmariah is an interventional cardiologist, structural heart and valve disease specialist, as well as a clinical and translational investigator at the Massachusetts General Hospital seeking to improve clinical outcomes for patients with valvular heart disease (VHD). He is an Assistant Professor of Medicine at the Harvard Medical School and serves as the Director of Interventional Cardiology Research.Dr. Elmariah graduated from the University of Pennsylvania School of Medicine and completed his internal medicine residency training at the Hospital of the University of Pennsylvania. Dr. Elmariah completed his fellowship in cardiovascular medicine at the Mount Sinai Hospital in New York and a Masters in Public Health degree at the Harvard School of Public Health. Dr. Elmariah completed further fellowship training in interventional cardiology and structural heart disease at the Massachusetts General Hospital.His clinical interest is in the management of valvular heart disease and in the transcatheter repair and replacement of aortic, mitral, and tricuspid valves. Dr. Elmariah is involved in a myriad of ongoing clinical investigations seeking to advance our understanding of the heart's response to aortic stenosis and also to identify informative biomarkers to help guide the timing of valve replacement procedures. In addition, Dr. Elmariah leads several ongoing clinical trials at MGH investigating novel devices for the management of mitral and tricuspid regurgitation and aortic stenosis. His research is funded by the National Institutes of Health, the American Heart Association, the US Department of Defense, and several industry partners.